Zhu Pirot, PhD

Vice President, Translational Sciences

Zhu Pirot is the Vice President of Translational Sciences at Kriya Therapeutics. Previously, Dr. Pirot was the head of analytical method development, CMC lead at Sangamo Therapeutics where she built and led the analytical function for AAV-mediated gene therapy, gene editing, and cell therapy programs. She has more than 20 years of experience in drug development and has held positions of increasing responsibility at Chiron, Avigen, and Geron.

Dr. Pirot received her Medical Degree from Inner Mongolia Medical College. She completed her master’s degree in Cytogenetics from Beijing Cancer Institute and her PhD in Cellular and Molecular Biology from the University of Turin.